Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127265421 | 12726542 | 1 | I | 201512 | 20160824 | 20160908 | 20160908 | EXP | GB-GLAXOSMITHKLINE-GB2016GSK124177 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160908 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127265421 | 12726542 | 1 | SS | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | UNK | N | 0 | ||||||||||
| 127265421 | 12726542 | 2 | PS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | U | 21077 | |||||||||||
| 127265421 | 12726542 | 3 | I | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | UNK | N | 0 | ||||||||||
| 127265421 | 12726542 | 4 | SS | EPADERM | MINERAL OILPETROLATUMWAX, EMULSIFYING | 1 | 0 | ||||||||||||
| 127265421 | 12726542 | 5 | SS | DETTOL FIRST AID ANTISEPTIC | CHLOROXYLENOL | 1 | U | 0 | |||||||||||
| 127265421 | 12726542 | 6 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | UNK | N | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127265421 | 12726542 | 1 | Product used for unknown indication |
| 127265421 | 12726542 | 2 | Chronic obstructive pulmonary disease |
| 127265421 | 12726542 | 4 | Psoriasis |
| 127265421 | 12726542 | 5 | Product used for unknown indication |
| 127265421 | 12726542 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127265421 | 12726542 | HO |
| 127265421 | 12726542 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127265421 | 12726542 | Abdominal pain | |
| 127265421 | 12726542 | Asthenia | |
| 127265421 | 12726542 | Asthma | |
| 127265421 | 12726542 | Autoimmune disorder | |
| 127265421 | 12726542 | Chest pain | |
| 127265421 | 12726542 | Diarrhoea | |
| 127265421 | 12726542 | Drug interaction | |
| 127265421 | 12726542 | Dyspnoea | |
| 127265421 | 12726542 | Food allergy | |
| 127265421 | 12726542 | Hypersensitivity | |
| 127265421 | 12726542 | Hypophagia | |
| 127265421 | 12726542 | Impaired quality of life | |
| 127265421 | 12726542 | Lower respiratory tract infection | |
| 127265421 | 12726542 | Movement disorder | |
| 127265421 | 12726542 | Pain | |
| 127265421 | 12726542 | Reaction to preservatives | |
| 127265421 | 12726542 | Rib fracture | |
| 127265421 | 12726542 | Urticaria | |
| 127265421 | 12726542 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127265421 | 12726542 | 1 | 20151220 | 0 | ||
| 127265421 | 12726542 | 6 | 2015 | 2015 | 0 |